7.98
Schlusskurs vom Vortag:
$7.85
Offen:
$7.95
24-Stunden-Volumen:
601.81K
Relative Volume:
0.82
Marktkapitalisierung:
$1.17B
Einnahmen:
$342.81M
Nettoeinkommen (Verlust:
$97.67M
KGV:
12.99
EPS:
0.6145
Netto-Cashflow:
$50.46M
1W Leistung:
-5.00%
1M Leistung:
-12.69%
6M Leistung:
+21.46%
1J Leistung:
-0.99%
Mimedx Group Inc Stock (MDXG) Company Profile
Firmenname
Mimedx Group Inc
Sektor
Branche
Telefon
(770) 651-9100
Adresse
1775 W OAK COMMONS COURT, NE, MARIETTA
Vergleichen Sie MDXG mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
6.49 | 0 | 0 | 0 | 0 | 0.00 | |
![]()
PSNYW
Polestar Automotive Holding Uk
|
0.194 | 409.41M | 2.07B | -1.42B | -1.37B | -0.6765 |
![]()
GOODO
Gladstone Commercial Corporation
|
20.38 | 372.90M | 0 | 0 | 0 | 0.00 |
![]()
MOBBW
Mobilicom Limited Warrants
|
0.57 | 278.60M | 0 | 0 | 0 | 0.00 |
![]()
SHMD
Schmid Group N V
|
2.66 | 114.55M | 0 | 0 | 0 | 0.00 |
![]()
JUNE
Dhandho Junoon Etf
|
4.1299 | 53.72M | 0 | 0 | 0 | 0.00 |
Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-07-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
2024-03-07 | Eingeleitet | Lake Street | Buy |
2023-10-27 | Eingeleitet | Craig Hallum | Buy |
2022-10-13 | Eingeleitet | Mizuho | Buy |
2021-07-26 | Eingeleitet | Northland Capital | Outperform |
2021-03-19 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Mimedx Group Inc Aktie (MDXG) Neueste Nachrichten
10,380 Shares in MiMedx Group, Inc. (NASDAQ:MDXG) Bought by Savant Capital LLC - Defense World
MiMedx Group, Inc. (MDXG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
MiMedx COO Ricci Whitlow sells $508,557 in company stock By Investing.com - Investing.com South Africa
MiMedx COO Ricci Whitlow sells $508,557 in company stock - Investing.com India
(MDXG) Investment Analysis and Advice - Stock Traders Daily
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers - GlobeNewswire Inc.
When (MDXG) Moves Investors should Listen - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Sold by Chicago Capital LLC - MarketBeat
Insiders At MiMedx Group Sold US$659k In Stock, Alluding To Potential Weakness - Simply Wall St
MIMEDX to Host Fourth Quarter and Full Year 2024 Operating and Financial Results Conference Call on February 26 - GlobeNewswire
MIMEDX Q4 2024 Earnings Call: Key Financial Results Coming February 26What to Watch - StockTitan
While shareholders of MiMedx Group (NASDAQ:MDXG) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Purchased by SG Americas Securities LLC - MarketBeat
MiMedx Group (NASDAQ:MDXG) Shares Up 5.8%Time to Buy? - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Price Target from Analysts - Defense World
MiMedx Group, Inc. to Host Earnings Call - ACCESS Newswire
(MDXG) Proactive Strategies - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Rating of "Buy" by Brokerages - MarketBeat
JPMorgan Chase & Co. Acquires 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
JPMorgan Chase & Co. Buys 215,995 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Analysts Set Expectations for MiMedx Group FY2025 Earnings - Defense World
MiMedx Group, Inc.'s (NASDAQ:MDXG) one-year returns climbed after last week's 6.2% gain, institutional investors must be happy - Simply Wall St
Cantor Fitzgerald Predicts MiMedx Group FY2025 Earnings - MarketBeat
MiMedx Group Updates Investor Presentation in Recent 8-K Filing - Defense World
Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily
Barclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
Barclays PLC Purchases 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
Tendonitis Pipeline Insights 2024: Therapies, Clinical Trials, MOA, ROA, and Developments | MetrioPharm, MiMedX group, InGeneron, Novartis, R3 Stem Cell - Barchart
MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St
Principal Financial Group Inc. Purchases 3,292 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
(MDXG) Trading Report - Stock Traders Daily
MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Target Price from Analysts - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Recommendation of "Buy" by Analysts - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Geode Capital Management LLC - Defense World
Northland Capmk Predicts MiMedx Group Q1 Earnings - MarketBeat
Northland Capmk Forecasts MiMedx Group Q1 Earnings - Defense World
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Barclays PLC - Defense World
Barclays PLC Has $1.55 Million Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
How the (MDXG) price action is used to our Advantage - Stock Traders Daily
Jane Street Group LLC Grows Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Jane Street Group LLC - Defense World
We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease - Simply Wall St
State Street Corp Lowers Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
State Street Corp Has $22.81 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat
MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Fmr LLC - Defense World
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 33,241 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World
MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com
MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire
MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com
MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan
MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com
Finanzdaten der Mimedx Group Inc-Aktie (MDXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):